Neurotoxins and monoamine oxidase inhibi
โ
Prof. K. T. Finnegan
๐
Article
๐
1993
๐
John Wiley and Sons
๐
English
โ 675 KB
Recent clinical studies suggest that selegiline (1.-deprenyl) is useful in retarding the progress of Parkinson's disease. an effect that may bc related to its inhibition of monoamine oxidase type B (MAO-B). Selegilinc is also reported to prevent the toxic effects of the norddrenergic neurotoxin, h~-